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Abstract Two gemini surfactants, [C18CysL5CCK8]2
and [C18CysDTPAGlu]2, containing, respectively, the
CCK8 peptide and the DTPAGlu chelating agent or its
gadolinium complex have been prepared by linking lipo-
philic chains through a disulfide bond between two cysteine
residues. The two surfactants aggregate in water solution
forming pure or mixed micelles, with a critical micellar
concentration in the 5 9 10-6–5 9 10-5 mol kg-1 range,
as measured by fluorescence spectroscopy. As indicated by
small-angle neutron scattering, the shape and size of the
micelles are influenced by the temperature: increasing
temperature leads to progressive reduction of the size of the
supramolecular aggregates. Cylindrical structures found at
lower temperatures (10–40 C) evolve into ellipsoidal
micelles at 50–80 C. Furthermore, the surface-exposed
CCK8 peptide changes its conformation above a transition
temperature of approximately 45 C, going from a b-sheet
to a random-coil structure, as indicated by circular dichro-
ism measurements. The mixed aggregate obtained by
coaggregation of the two gemini-based amphiphilic com-
pounds, [C18CysDTPAGlu(Gd)]2 and [C18CysL5CCK8]2
in 70:30 molar ratio, represents the first example of a
peptide-containing gemini surfactant as a potential
target-selective contrast agent in MRI. In fact, it presents a
high relaxivity value of the gadolinium complex,
21.5 mM-1 s-1, and the CCK8 bioactive peptide exposed
on the external surface is therefore capable of selective
targeting of the cholecystokinin receptors.
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Introduction
Over the past two decades magnetic resonance imaging
(MRI) has evolved into one of the most versatile and effi-
cient noninvasive tools for clinical diagnosis [1, 2]. The
advent of high magnetic fields, improved gradient coils, and
pulse sequences has provided the means to obtain three-
dimensional images of the internal part of the body at near
cellular resolution [3]. The resolution of the image can be
improved by administration of contrast agents. Stable
complexes of gadolinium ion with polyaminocarboxylate
ligands have been extensively used as paramagnetic
contrast agents for MRI [4], because of their high
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paramagnetism (seven unpaired electrons) and because of
their favorable properties in terms of electronic relaxation
[5]. The relative ability of a paramagnetic Gd(III) complex
to act as an MRI contrast agent is expressed by its relaxivity,
which measures the relaxation enhancement of water pro-
tons in solution containing the paramagnetic agent at 1 mM
concentration [6]. Many efforts have been devoted to
improving the relaxivity of Gd(III)-based contrast agents.
As recognized early, high relaxivities can be achieved for
slow-moving systems endowed with long rotational corre-
lation times, fast exchange rates of the coordinated water
molecules, and suitably long electronic relaxation rates of
the unpaired electrons on the metal ion [1, 4].
On this basis several macromolecular systems have been
designed in which the Gd(III) complexes are either cova-
lently or noncovalently bound to high molecular weight
substrates. Many supramolecular systems have been devel-
oped, such as dendrimers [7], polymers [8], proteins [9],
water–gadofullerenes [10], and supramolecular amphiphilic
aggregates such as micelles [11] and liposomes [12].
Among these carriers, micelles and liposomes, because
of their easily controlled properties and good pharmaco-
logical characteristics, such as long blood retention, high
tissue perfusion or excretion, are very promising candidates
as contrast agents. The molecular targeting of supramo-
lecular aggregates containing contrast agents might be
accomplished by conjugating active recognition moieties,
such as peptides [13] or antibodies [14], to their surface.
For example, these bioactive markers could deliver
the aggregates to membrane receptors overexpressed by
cancerous cells [15].
We have recently developed mixed micellar aggregates
containing a large number of gadolinium complexes and
several units of a bioactive peptide, coupling together in
the same contrast agent the high relaxivity due to the large
number of paramagnetic complexes and the target speci-
ficity of the bioactive peptide [11, 16–18]. The CCK8
peptide (amino acid sequence Asp-Tyr-Met-Gly-Trp-Met-
Asp-Phe-amide) is the C-terminal end of the peptide hor-
mone cholecystokinin. This bioactive peptide should be
able to deliver the aggregates on the cholecystokinin
receptors CCKA-R and/or CCKB-R [19]. In this paper we
describe new pure and mixed supramolecular structures in
which both the amphiphilic monomers are represented by
‘‘gemini’’ surfactants. In general, as is well known, gemini
surfactants are formed by the covalent linking of two
‘‘conventional’’ surfactants via a spacer [20, 21]. These
surfactants have interesting features, such as low critical
micellar concentration (cmc) values, which drastically
reduce cytolytic action on the cell membrane. By manip-
ulating the molecular architecture and the solution
conditions, one can obtain a variety of supramolecular
aggregates, such as vesicles and micelles. In the last few
years, Camilleri et al. proposed a novel class of peptide-
based cationic gemini surfactants as nonviral gene-transfer
vectors. These gemini surfactants include C12 saturated
hydrocarbon ‘‘tails’’ and a short peptide ‘‘head group’’ with
one or more basic amino acid residues. They were syn-
thesized by starting from the reaction of L-cysteine with
dibromoethane to form the bisthioether [22, 23] or by using
a spermine molecule as a linker [24]. We have developed a
new synthetic procedure in the solid phase to easily obtain
gemini-based peptide surfactants by introducing a cysteine
residue in the peptide sequence. This strategy allows
disulfur-bridge formation under mild oxidative conditions,
reducing the number of purification steps. The new strategy
was applied in the work reported here for the achievement
of two gemini surfactants: one containing the bioac-
tive sequence of the cholecystokinin peptide CCK8,
[C18CysL5CCK8]2, and the other one containing the
chelating agent DTPAGlu or its gadolinium complex,
DTPAGlu(Gd), [C18CysDTPAGlu(Gd)]2 (see Fig. 1). We
also report on the structural characterization and on the
relaxivity behavior of supramolecular aggregates obtained
by coassembling the two synthetic gemini surfactants at
70:30 molar ratio between the chelating monomer or its
corresponding gadolinium complex and peptide monomer.
Moreover, on the basis of recent reports in the literature
which suggest conformational changes of the peptide upon
temperature increase [25, 26] and to highlight the structural
behavior of these aggregates as function of temperature
[27, 28], we also performed structural investigations over a
wide temperature range. These supramolecular aggregates
represent the first example of peptide-containing gemini
surfactants as potential target-selective contrast agents in
MRI.
Results and discussion
Both gemini surfactants were synthesized by solid-phase
methods using Rink amide 4-methylbenzhydrylamine
(MBHA) resin as a polymeric support and 9-fluorenyl-
methoxycarbonyl(Fmoc)/t-Bu chemistry according to
standard solid phase peptide synthesis protocols [29]. After
the cleavage from the resin, the crude monotailed products
were dissolved in an ammonium hydrogen carbonate
solution (pH 8.0–8.5) and stirred at room temperature for
24 h [see Fig. S1 for liquid chromatography (LC)–mass
spectrometry (MS) data of crude products). The oxidation
reactions were followed by using the colorimetric Ellmann
test [30]. In Fig. 2 the 1H NMR spectrum of C18Cys-
DTPAGlu monomer in dimethyl-d6 sulfoxide (DMSO-d6)
before its oxidation to the corresponding gemini surfactant
is shown. The NMR spectrum confirms the high purity of
the product, allowing a good yield of the oxidized gemini
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surfactant. As is clearly visible in the enlarged low-field
region, the spectrum presents a broad signal (7.80 d) cor-
responding to the eNH-Lys proton, and two doublets related
to aNH amide protons of the Cys–Lys fragment. These
signals (8.05 and 7.90 d) are shifted at high field compared
with the NH signal in random-coil peptide chains (8.40–
8.30 d). The [C18CysL5CCK8]2 gemini surfactant was
purified by preparative reversed-phase high-performance
LC (HPLC) to a final HPLC purity of 90% and was isolated
in 25% yield in lyophilized form. Analytical LC-MS data
confirm the identity of the compound and its high purity.
The gadolinium complex of [C18CysDTPAGlu]2 was
prepared by adding 2 equiv of GdCl3 to a [C18Cys-
DTPAGlu]2 ligand solution at neutral pH and room
temperature. To avoid the relaxivity contribution of free
gadolinium ion, the excess was removed by filtering the
complex solution left at pH 10 for 24 h with a 0.2-lm
syringe filter, as already reported for other chelating
amphiphilic monomers [11]. The xylenol orange UV-
spectrophotometric method was used to check for the
absence of free Gd(III) ions [31]. Self-assembling and
mixed supramolecular aggregates were obtained by simply
dissolving [C18CysDTPAGlu]2 (or its corresponding gad-
olinium complex) and [C18CysL5CCK8]2 gemini
surfactants in phosphate buffer at pH 7.4.
Structural characterization
Fluorescence measurements
Cmc values of [C18CysDTPAGlu]2–H2O, [C18CysDTP-
AGlu(Gd)]2–H2O, and [C18CysL5CCK8]2–H2O binary
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Fig. 1 [C18CysDTPAGlu(Gd)]2 and [C18CysL5CCK8]2 gemini amphiphilic monomers, obtained by connecting two identical moieties by a
disulfide bond
Fig. 2 1H NMR spectrum of
C18CysDTPAGlu in dimethyl-
d6 sulfoxide
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systems and of [C18CysDTPAGlu]2–[C18CysL5CCK8]2–
H2O and [C18CysDTPAGlu(Gd)]2–[C18CysL5CCK8]2–
H2O ternary systems were determined by steady-state
fluorescence spectroscopy by using, in separate experi-
ments, two different probes: 8-anilinonaphthalene-1-
sulfonate (ANS) and pyrene. The cmc measurements by
two independent experiments allow minimization of the
uncertainty in the calculated values. ANS and pyrene are
both fluorescent probes that are poorly soluble in aqueous
solution that change their emission spectrum depending on
the polarity of the environment (hydrophobic or hydro-
philic). The ANS fluorophore fluoresces at 480 nm only in
a hydrophobic environment such as the inner micelle core
[32]; thus, when the fluorescence intensity at 480 nm is
plotted as a function of the amphiphile concentration,
the breakpoint indicates the cmc value (see Fig. 3a, c,
Table 1). In contrast, the pyrene molecule shows a more
complex emission spectrum composed of five emission
peaks (373, 379, 383, 389, and 393 nm). These peaks are
affected by the polarity of the surrounding environment of
the probe molecules. Specifically, it is considered that the
I1/I3 ratio of pyrene fluorescence is an index of the polarity
of its environment. The values in hydrophobic solvents
vary in the range 0.57–0.61, while in polar solvents the
range is 1.25–2.00. In a micellar medium the observed
values can be explained in terms of penetration of water
into micelles and of the type of surfactant head group
[33, 34].
As shown in Fig. 3b and d, the ratio between the inten-
sities of the first (I1) and the third (I3) vibration bands of the
pyrene emission spectrum remains constant (approximately
1.4–1.5) at monomer concentrations c B 10-6 mol kg-1,
thus indicating the absence of micellar aggregates. At
higher concentrations (c [ 10-6 mol kg-1) I1/I3 decreases,
thus indicating surfactant aggregation and pyrene migration
from the aqueous environment into the hydrophobic core
(or at the core–corona interface). Even though it has been
reported that the polarity of the outer layer of the micelles
could influence the pyrene emission [35], the cmc values
obtained by using ANS and pyrene methods are in good
agreement and indicate that all monomers in aqueous
solution aggregate above a molal concentration in the
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Fig. 3 a, c Fluorescence
intensity of the 8-
anilinonaphthalene-1-sulfonate
fluorophore at 480 nm and b, d
I1/I3 ratio of the pyrene
vibration band versus surfactant
concentration:
[C18CysDTPAGlu]2–H2O
(squares); [C18CysL5CCK8]2–
H2O (open circles);
[C18CysDTPAGlu(Gd)]2–H2O
(filled circles);
[C18CysDTPAGlu]2–
[C18CysL5CCK8]2–H2O
(open triangles);
[C18CysDTPAGlu(Gd)]2–
[C18CysL5CCK8]2–H2O
(filled triangles). The data were
multiplied by a scale factor for
better comparison
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5 9 10-6–5 9 10-5 mol kg-1 range (see Table 1). These
values are only slightly lower than the cmc values for the
aggregates previously obtained by self-assembly of mono-
tailed monomers (5 9 10-5 mol kg-1) [11, 36]. This
experimental result is apparently in disagreement with the
well-known gemini surfactant properties, consisting of the
ability of gemini surfactants to aggregate at cmc values
lower than those of the monotailed monomers. In more
detail, [C18CysDTPAGlu]2 has a cmc value of approxi-
mately 4.6 9 10-6 mol kg-1, while the corresponding
monotailed monomer C18DTPAGlu has a cmc value of
5 9 10-5 mol kg-1. These results can be explained taking
into account the high electrostatic repulsion between the
negative charges of the [C18CysDTPAGlu]2 head groups.
This monomer contains two DTPAGlu chelating agents in
the same molecule, where each DTPAGlu moiety has five
negative charges (COO-) at physiological pH, or two
negative charges after gadolinium complexation. The cmc
values are slightly higher than those found for double-tailed
amphiphiles bearing only one charged DTPAGlu head
group [16]. Hence, in the gemini compound two different
effects are present : the higher tendency to aggregate with
respect to the monotailed monomers, and the higher elec-
trostatic repulsion between the head groups due to the
negative charges of DTPAGlu moieties. The combination
of these two effects produces (1) a slight stabilization of the
gemini compound with a cmc value only 1 order of mag-
nitude lower than for the monotailed monomer and (2) a
slight loss in stability with respect to (C18)2DTPAGlu. The
cmc value (approximately 6 9 10-6 mol kg-1) found for
[C18CysL5CCK8]2 monomer, in which there are no
repulsion effects, is in agreement with the low expected
values for gemini surfactants. In fact, the corresponding
monotailed monomer (C18L5CCK8) did not show any
tendency to aggregate under the same experimental condi-
tions [36]. Moreover, fluorescence spectroscopy was used
to confirm the presence of the bioactive peptide that is well
exposed on the aggregate external surface: fluorescence at
approximately 360 nm of the tryptophan indole moiety
(Fig. S2) is indicative of the presence of a tryptophan
residue in a polar aqueous solvent, suggesting the presence
of the entire CCK8 peptide in the micellar external
environment.
Circular dichroism
The secondary peptide structures in pure aggregates formed
by [C18CysL5CCK8]2 and in [C18CysDTPAGlu]2–
[C18CysL5CCK8]2 mixed aggregates [and the corre-
sponding system in which the DTPAGlu chelating agent
complexes the Gd(III) ion] were evaluated by circular
dichroism (CD) spectroscopy. As was expected for short
peptide sequences [37], and as previously reported [38, 39],
the CCK8 octapeptide moiety does not undergo any folding
process in water solution. On the other hand, in micellar
aggregates obtained by self-assembly of (C18)2L5CCK8,
the peptide shows a classic b-sheet fold [40]. This result
suggests that the hydrogen bonds among amino acids, well
exposed on the external surface of the aggregates, promote
intermolecular sheet-like structures that are stabilized by
interactions between the alkyl chains. In the present case,
according to the previous results, the CD spectrum of
[C18CysL5CCK8]2 reveals the characteristic shape of a b-
sheet-type structure (Fig. 4). Upon heating the solution, the
intensity of the CD spectra of the b-sheet structure signals
(222 nm) decreases linearly, suggesting the breaking up of
the interactions between peptides that are near each other.
By plotting the intensity of the CD spectra at 222 nm as a
function of temperature, one obtains a sigmoid curve
composed of three temperature ranges: in the first one (from
10 C to approximately 20 C) the CD signal remains
constant; in the second one (from approximately 20 C to
approximately 60 C) there is a progressive decrease of the
CD signal; and in the last one (from approximately 60 C to
80 C) the signal intensity remains constant. The maximum
in the first derivative of the sigmoid curve indicates the
transition temperature (Tt * 45 C) at which the peptide
structure changes from a b-sheet to a random-coil structure.
The random-coil structure observed at 80 C persists when
the samples are cooled down. The peptide b-sheet confor-
mation seems to be again obtained only below 20 C,
indicating a hysteresis phenomenon at the cooling rate used
(1 C min-1). Similar structural behavior of the CCK8
peptide is observed in the case of the two mixed aggregates
[C18CysDTPAGlu]2–[C18CysL5CCK8]2 and [C18Cys-
DTPAGlu(Gd)]2–[C18CysL5CCK8]2, with Tt values in the
same range (Fig. 5), and the presence of the hysteresis
phenomenon. This result indicates that in mixed micelles,
in which the two monomers [C18CysDTPAGlu]2 and
[C18CysL5CCK8]2 are combined in 70:30 molar
ratio, CCK8 molecules, notwithstanding their dilution in
Table 1 Critical micellar concentration (cmc) values of supramo-
lecular aggregates determined by steady-state fluorescence
spectroscopy using 8-anilinonaphthalene-1-sulfonate (ANS) and pyr-
ene as probes
System ANS cmc
(mol kg-1)
Pyrene cmc
(mol kg-1)
[C18CysDTPAGlu]2–H2O 4.3 9 10
-6 4.8 9 10-6
[C18CysDTPAGlu(Gd)]2–H2O 1.0 9 10
-5 1.5 9 10-5
[C18CysL5CCK8]2–H2O 5.5 9 10
-6 6.5 9 10-6
[C18CysDTPAGlu]2–
[C18CysL5CCK8]2–H2O
5.3 9 10-5 5.6 9 10-5
[C18CysDTPAGlu(Gd)]2–
[C18CysL5CCK8]2–H2O
8.0 9 10-6 8.0 9 10-6
See Fig. 1 for the molecular structures
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[C18CysDTPAGlu]2 aggregates, are still close enough to
each other to maintain hydrogen bonds among peptide
chains.
Small-angle neutron scattering
Small-angle neutron scattering (SANS) provides a direct
probe of aggregate structure in dilute solutions. Figure 6
show the scattering cross sections collected for the
[C18CysDTPAGlu(Gd)]2 (1.40 mmol kg
-1)–[C18CysL5-
CCK8]2 (0.60 mmol kg
-1)–D2O ternary system. The
scattering cross sections for the [C18CysL5CCK8]2 binary
system and for the corresponding ternary systems contain-
ing [C18CysDTPAGlu]2 are reported in Figs. S3 and S4.
Figure 6a shows cross sections measured with temperature
increasing, at 10, 40, 60, and 80 C, and Fig. 6b shows cross
sections measured with temperature decreasing, at 50, 20,
and 10 C. Inspection of the data shows some characteristic
behavior for all the systems. The absence of a peak or
depression of the signal at lower q suggests minimal, if any,
intermicellar S(q) interaction, as would be expected at these
low concentrations in a 0.1 M buffer solution.
At 10 and 40 C in Fig. 6a, the intensity for the initially
prepared solutions scales with a dR/dX  q-1 power
law characteristic of elongated structures (i.e., rod-like
micelles). Owing to the lack of the Guinier regime for such
temperatures, it is possible only to estimate that the length l
of the cylinders should be greater than 2p/qmin, where qmin is
the smallest q value explored with the SANS measurements.
The length of the rods is thus likely to be more than 700 A˚.
The radius of the cylindrical structures can be found from the
axial Guinier equation for long, thin, rigid rods [41]:
1n q
dR
dX
 
¼ 1n / 1  /ð ÞpR2D2q  q2R2
4
: ð1Þ
By fitting of Eq. 1 in the q range where q  p/R,
cylindrical radii R of 19–24 A˚ were obtained, as reported in
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Fig. 4 Circular dichroism spectra of 1 9 10-4 M [C18CysL5-
CCK8]2 aggregate solution at pH 7.4: a aggregate solution heated
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Fig. 5 Circular dichroism spectra of the [C18CysDTPAGlu(Gd)]2–
[C18CysL5CCK8]2–H2O ternary system (70:30 molar ratio, pH 7.4,
1 9 10-4 M concentration of the peptide-containing gemini surfac-
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Table 2. It is worth noting that the flat background was
taken into account for correct evaluation of the radius.
Upon increasing the temperature above 40 C, the
aggregates change shape and the data suggest a form
factor typical of ellipsoidal aggregates (see Figs. 6b, S3,
S4). This behavior holds up to the highest temperature
investigated (80 C) and persists even when the samples
are cooled down: the structural features seem to be
preserved even if the initial temperature (10 C) is again
reached. Thus, we are in the presence of a hysteresis
phenomenon. Scattering cross sections were modeled for a
collection of monodisperse ellipsoidal micelles with an
aggregation number Nagg of surfactant molecules with
volume v. When significant interactions among the
aggregates can be excluded, the scattering cross sections
dR/dX can be expressed as [42]
dR
dX
¼ npP qð Þ þ dR
dX
 
incoh
; ð2Þ
where np is the number density of scattering bodies, P(q) is
the form factor of the bodies, and (dR/dX)incoh is the
incoherent scattering cross section. By modeling the
micelles as uniform ellipsoids with semiaxes a, b = c,
one can write the function P(q) as
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Fig. 6 Scattering cross sections
measured on heating (a) and
cooling (b) the
[C18CysDTPAGlu(Gd)]2
(1.40 mmol kg-1)–
[C18CysL5CCK8]2
(0.60 mmol kg-1)–D2O system,
at the temperatures reported. To
make the data more readable,
cross sections were multiplied
by a scale factor, as indicated
Table 2 Structural parameters obtained from fitting to small angle neutron scattering data at different temperatures
10 C 40 C 50 C 60 C 80 C 50 C 20 C 10 C
[C18CysL5CCK8]2 (1.00 mmol kg
-1)–D2O
Nagg –
a –a – 16 ± 1 15 ± 1 14 ± 1 14 ± 1 13 ± 1
R (A˚) 21 ± 1 22 ± 1 –
a (A˚) – 43 ± 2 42 ± 2 41 ± 2 41 ± 2 40 ± 2
b = c (A˚) – 25 ± 1 25 ± 1 24 ± 1 24 ± 1 24 ± 1
[C18CysDTPAGlu(Gd)]2 (1.40 mmol kg
-1)–[C18CysL5CCK8]2 (0.60 mmol kg
-1)–D2O
Nagg –
a –a 26 ± 1 22 ± 1 23 ± 1 22 ± 1 21 ± 1 21 ± 1
R (A˚) 24 ± 1 23 ± 1
a (A˚) 57 ± 2 43 ± 2 46 ± 2 44 ± 2 44 ± 2 42 ± 2
b = c (A˚) 24 ± 1 25 ± 1 25 ± 1 25 ± 1 25 ± 1 25 ± 1
[C18CysDTPAGlu]2 (1.40 mmol kg
-1)–[C18CysL5CCK8]2 (0.60 mmol kg
-1)–D2O
Nagg –
a –a 26 ± 1 25 ± 2 21 ± 1 21 ± 1 22 ± 1 23 ± 1
R (A˚) 23 ± 1 19 ± 1
a (A˚) 57 ± 2 46 ± 2 44 ± 2 47 ± 2 46 ± 2 44 ± 2
b = c (A˚) 24 ± 1 24 ± 1 25 ± 1 24 ± 1 25 ± 1 26 ± 1
The equations used for the fitting are in the text. The radius (R) of cylindrical aggregates obtained at lower temperature is reported in the first two
columns; the length of the semiaxis (a, b = c) of ellipsoidal micelles found at higher temperature and by cooling them to 10 C is reported in the
other columns
a The aggregation number, Nagg, is not measurable in the case of cylindrical aggregates
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P qð Þ ¼ Dqð Þ2V2
Z1
0
F q; lð Þ2dl; ð3Þ
where F(q,l) is the angle-dependent form factor for
ellipsoidal micelles
F q; lð Þ ¼ 3j1 uð Þ
u
; ð4Þ
with
u ¼ q
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
l2a2 þ 1  l2ð Þb2
p
; ð5Þ
where j1 is the spherical Bessel function of first order,
V = 4/3pab2 = vNagg is the micellar volume, and Dq is the
contrast existing between the micelles and the solvent. By
using Eqs. 2, 3, 4, and 5, we obtained structural informa-
tion on the aggregates present in the system and this is
reported in Table 2.
Inspection of Table 2 reveals that micellar aggregates
have elongated shapes with a cylindrical structure at lower
temperatures and ellipsoidal shapes (with an axes ratio of
approximately 2) at higher temperatures. The similar val-
ues observed for the radius of the cylindrical structures and
for the minor semiaxis of the ellipsoidal structures suggest
that the increase of the temperature leads to progressive
shortening of the cylindrical structures to ellipsoidal
micelles. Furthermore, the cooling of the systems again to
10 C, once they have reached the maximum temperature
investigated (80 C), does not produce a significant change
in the size and shape of the micelles.
Relaxivity measurements
The measured relaxivity value (r1p) is defined, according to
Eq. 6, as the paramagnetic contribution to the measured
proton longitudinal relaxation rate (R1obs) of a solution
containing 1.0 mM concentration of the paramagnetic
solute:
Rlobs ¼ Gd½ r1p þ R1W; ð6Þ
where R1w is the diamagnetic contribution of pure water
(0.38 s-1). Relaxivity values at 20 MHz and 25 C
(Table 3) were determined by mineralizing a 100-ll sam-
ple with 100 ll of 37% HCl at 120 C overnight to
determine the exact concentration of Gd(III) present in the
solutions.
This mineralization process leads to a complete
destruction of the gadolinium complex with the consequent
release of free Gd(III) aquaion in the acidic solution. From
the value of the observed relaxation rate (R1obs) of this acidic
solution, and knowing the relaxivity (r1p) of Gd(III) aquaion
in acidic conditions (13.5 mM-1 s-1 at 20 MHz and
25 C—GdCl3 solutions whose concentrations were mea-
sured by inductively coupled plasma MS were used as
standards, accuracy ±0.1%) and the diamagnetic contribu-
tion (R1w) in acidic conditions (0.5 mM
-1 s-1), we
calculated the exact Gd(III) concentration using Eq. 6.
Then, knowing the GdL concentration (opportunely cor-
rected for the 1:1 acidic dilution) and measuring R1obs of the
aggregate-containing sample solutions, we calculated the
relaxivity values of the two systems considered using again
Eq. 6. The relaxivity measurements were performed on
samples at a concentration much higher than the cmc: under
these conditions, the contribution of monomeric species is
negligible, and only aggregates are responsible for the
measured relaxivity values. All the relaxometric character-
ization was conducted at 25 C, that is, in the temperature
conditions for which micelles have a rod-like cylindrical
shape. The relaxivity values determined at 25 C and
20 MHz are 18.4 and 21.5 mM-1 s-1 for pure and mixed
micelles respectively. These values are in accordance with
those of other similar gadolinium-containing micellar sys-
tems, as almost all the q = 1 (one inner-sphere water
molecule) gadolinium-based micelles have relaxivity values
in the range 18–23 mM-1 s-1 (20 MHz, 25 C) [43–45]. To
reach high relaxivity values, a very important parameter to
account for is the exchange lifetime of the coordinated water
molecule (sM) of a Gd(III) complex. The analysis of the
temperature dependence of the transverse relaxation rate of
the metal-bound 17O water resonance may be considered the
method of choice for the determination of sM values [46,
47]. The sM value determined for the [C18CysDTPA-
Glu(Gd)]2 self-assembling aggregate at 25 C and neutral
pH was 152 ns. In the case of the [C18CysDTPAGlu(Gd)]2–
Table 3 Principal relaxometric parameters measured at pH 7.4, 25 C, and 20 MHz, calculated from fitting the nuclear magnetic relaxation
dispersion (sR, D
2, sV) and
17O NMR (sM) data as described in the text
System r1p
(mM-1 s-1)
sM (ns) sR (ns) D
2
(91018 s-2)
sV (ps)
sl S sg
[C18CysDTPAGlu(Gd)]2–H2O 18.4 152 0.190 0.49 3.20 7.65 57.3
[C18CysDTPAGlu(Gd)]2–[C18CysL5CCK8]2–H2O 21.5 152
a 0.533 0.41 3.20 9.09 50.0
a The exchange lifetime of the peptide-containing system was assumed to be similar to that of the corresponding system not containing the
peptide
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[C18CysL5CCK8]2 mixed aggregate the sM value was
assumed to be the same as that of the pure [C18Cys-
DTPAGlu(Gd)]2. From a quantitative analysis of the nuclear
magnetic relaxation dispersion (NMRD) profiles it is pos-
sible to determine the reorientational correlation time (sR),
which is related to the size of the system investigated. The
NMRD profiles of [C18CysDTPAGlu(Gd)]2 and [C18Cys-
DTPAGlu(Gd)]2–[C18CysL5CCK8]2 at 25 C are reported
in Fig. 7. For the micellar systems, the data were analyzed
using the Solomon–Bloembergen–Morgan model modified
according to the Lipari–Szabo approach [48, 49]. This
approach distinguishes between two independent motions: a
rapid local motion governed by a correlation time defined as
sl and a slower global motion with a correlation time defined
as sg. Data resulting from the fitting of the NMRD profiles
are reported in Table 3. The analysis of experimental data
gave the same value for sg of the two gadolinium-containing
systems, that is, only slightly higher than the values reported
for other gadolinium-based micellar systems [46].
The two systems differ substantially in the value of sl as
it seems that in mixed micelles containing the CCK8
amphiphilic moiety the internal motility of gadolinium-
containing units is reduced. Clearly the complexes give rise
to a system with a slower molecular tumbling in compar-
ison with isolated gadolinium complexes. Anyway, the
resulting relaxivity appears still lower than the expected
values as internal motions are faster than the overall tum-
bling of the micellar system. According to the recent theory
of Nicolle et al. [50], a relaxivity value lower than the
theoretic one can be also ascribed to the interactions
between nearby paramagnetic centers in micellar systems
which increase the transverse electronic relaxation of the
electron spins of Gd(III) and, therefore, reduce the attain-
able water proton relaxivity. In this case, the proximity
between Gd(III) centers is not only given by micellar
assembly but also by the dimeric nature of the amphiphilic
units.
Conclusion
The new gemini surfactants [C18CysL5CCK8]2 and
[C18CysDTPAGlu]2 or its gadolinium complex [C18Cys-
DTPAGlu(Gd)]2 were prepared following a new efficient
synthetic strategy. According to this strategy, amphiphilic
monomers are synthesized using solid-phase methods, and
after purification they are linked together through a disul-
fide bond between two cysteine residues, to give the
corresponding gemini surfactants.
Gadolinium-based paramagnetic supramolecular aggre-
gates derivatized with bioactive peptides, acting as
selective contrast agents, have already been developed, by
us and others, using different synthetic approaches [51, 52].
They are capable of visualizing neovascularization and
angiogenic processes targeting avb3 integrins or tumor
proliferation and metastasis, targeting cellular receptors
overexpressed by cancer cells. The choice of synthetic
strategy depends on whether coupling is performed before
or after assembly of the supramolecular aggregate. The
obvious goal of each approach is to achieve high coupling
efficiency, but with the ligand retaining full binding affinity
for its target receptor. The coupling of a ligand after the
aggregate has been assembled involves the introduction of
suitable activated functional groups onto the terminus of
one of the aggregate components. Labeling procedures,
based on the use of amphiphilic peptides that assemble
together with amphiphilic gadolinium complexes in the
peptide-labeled supramolecular aggregates, are very
effective and have been used by us to have CCK8-labeled
paramagnetic micelles and liposomes [11, 16–18]. The
supramolecular aggregates reported here were structurally
identified as cylindrical or ellipsoidal micelles. The shape
and size of the micelles are influenced by the temperature:
at lower temperatures micellar aggregates have elongated
shapes with a cylindrical structure, while at higher tem-
peratures ellipsoidal shapes are found. It seems that the
increase of the temperature leads to progressive shortening
of the cylindrical structures to ellipsoidal micelles. Like-
wise, the surface-exposed CCK8 peptide changes its
conformation on increasing the temperature, going from a
b-sheet to a random-coil structure. Even if there is any
evidence that the two phenomena are related, the similarity
of the transition temperatures of the two processes as well
as the amplitude of the hysteresis indicate a possible
34
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Fig. 7 Nuclear magnetic resonance dispersion profiles of [C18Cys-
DTPAGlu(Gd)]2 (filled squares) and [C18CysDTPAGlu(Gd)]2–
[C18CysL5CCK8]2 (open squares) obtained at pH 7.4 and 25 C,
normalized to 1 mM concentration of Gd(III) ion. The curves through
the data points were calculated with the parameters reported in
Table 3
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cooperation between the aggregate structure transition and
the peptide conformation variation. The aggregates
obtained by coaggregation of the two gemini-surfactant-
based amphiphilic compounds, [C18CysDTPAGlu(Gd)]2
and [C18CysL5CCK8]2 in 70:30 molar ratio, represent the
first example of peptide-containing gemini surfactants as
potential target-selective contrast agents in MRI. The high
relaxivity value, 21.5 mM-1 s-1, and the presence of
CCK8 bioactive peptide exposed on the external surface of
the micellar aggregate make this compound very attractive
as an MRI contrast agent for in vivo visualization of tumor
cells overexpressing the cholecystokinin receptors [53].
Materials and methods
Materials
Protected Na-Fmoc-amino acid derivatives, coupling
reagents and Rink amide MBHA resin were purchased
from Calbiochem-Novabiochem (Laufelfingen, Switzer-
land). Fmoc-8-amino-3,6-dioxaoctanoic acid (Fmoc-
AdOO-OH) was purchased from Neosystem (Strasbourg,
France). The DTPAGlu pentaester, N,N-bis[2-[bis[2-(1,1-
dimethyletoxy)-2-oxoethyl]-amino]ethyl]-L-glutamic acid
1-(1,1-dimethylethyl)ester, was prepared according to the
experimental procedure reported in the literature [54]. All
other chemicals were commercially available from Sigma-
Aldrich, Fluka (Buchs, Switzerland), or LabScan (Stillor-
gan, Dublin, Ireland) and were used as received unless
stated otherwise. All solutions were prepared by weight
using doubly distilled water. Samples to be measured by
SANS techniques were prepared using D2O (Sigma-
Aldrich, purity better than 99.8%). The pH of all solutions
was kept constant at 7.4. Preparative HPLCs were carried
out using an LC8 Shimadzu HPLC system (Shimadzu,
Kyoto, Japan) equipped with a UV lambda-Max model 481
detector using a Phenomenex (Torrance, CA, USA) C4
column (300 A˚, 250 mm 9 21.20 mm, 5 lm) eluted with
H2O/0.1% trifluoroacetic acid (TFA) (solvent A) and
CH3CN/0.1% TFA (solvent B) from 20 to 95% over
25 min at 20 mL min-1 flow rate. LC-MS analysis was
performed using a Thermo Electron (Waltham, MA, USA)
Finnigan system.
[C18CysL5CCK8]2
Peptide synthesis was carried out in the solid phase with a
standard Fmoc strategy [29], by using an Applied Biosys-
tems 433A automatic synthesizer. Rink amide MBHA resin
(0.78 mmol g-1, 0.5 mmol scale, 0.640 g) was used. The
elongation of the G-CCK8 peptide was achieved by
sequential addition of Fmoc-amino acids with ben-
zotriazol-1-yl-oxy-tris(pyrrolidinophosphonium) (PyBop)/
1-hydroxybenzotriazole (HOBt) and N,N-diisopropyleth-
ylamine (DIPEA) (1:1:2) as coupling reagents, in
dimethylformamide (DMF) in preactivation mode. The
mixture was stirred for 1 h and after filtration the corre-
sponding colorimetric test (Kaiser test) indicated the
completion of the coupling. All couplings were performed
twice for 1 h, by using an excess of 4 equiv for the single
amino acid derivative. Fmoc deprotections were obtained
using a 30% solution of piperidine in DMF. When the
peptide synthesis was complete, the Fmoc N-terminal
protecting group was removed and the five residues of
Fmoc-AdOO-OH were condensed, step by step, according
to the single coupling procedure by using an excess of
2 equiv. Then, the resin was washed and the terminal Fmoc
protection was removed. A 1.171-g (2.0-mmol) amount of
FmocCys(triphenylmethyl)-OH was coupled on the resin
under stirring. The solution was filtered, the resin washed
with three portions of DMF, and the Fmoc protecting group
of the cysteine residue removed. To obtain the lipophylic
monomer, 0.596 g (2.0 mmol) of nonaoctanoic acid was
coupled on the linker-peptide N-terminus by using 1.040 g
(2.0 mmol) of PyBop, 0.270 g (2.0 mmol) of HOBt, and
0.668 mL (4.0 mmol) of DIPEA in 4 mL of a 1:1 mixture
of DMF and dichloromethane (DCM). The coupling time
was 1 h under stirring at room temperature. For deprotec-
tion and cleavage, the fully protected resin was treated with
a TFA solution containing triisopropylsylane (TIS) (2.0%)
and water (2.5%) as scavengers. The free peptide deriva-
tive was precipitated in cold ethyl ether (Et2O) and
lyophilized from a H2O/CH3CN solution. The analytic LC-
MS analysis confirmed the identity of the product.
C18H37CO-Cys-(AdOO)5-G-CCK8 (C18CysL5CCK8):
Rt = 20.65 min; [M ? 3H]
?/3 = 741 amu (molecular
weight 2,228).
The intramolecular disulfur bond between cysteine res-
idues was obtained by reaction of the crude product
(0.1 mmol; 223 mg) dissolved in 100 mL of 0.1 M
ammonium hydrogen carbonate (pH 8.0–8.5) at room
temperature for 24 h. The air-oxidation reaction was
monitored by the colorimetric Ellmann test [30]. The
identification of the oxidized product was confirmed
by LC-MS analysis. The crude compound was purified by
reversed-phase HPLC. Fractions were characterized by
LC-MS analysis to assess purity and molecular weight.
Pure fractions were pooled and lyophilized. The total
amount of the oxidized gemini product was 550 mg, cor-
responding to a final yield of 25%. LC-MS characterization
confirmed the identity of the oxidized gemini product.
[C18H37CO-Cys-(AdOO)5-G-CCK8]2; Rt = 26.76 min;
[M ? 3H]?/3 = 1,485 amu (molecular weight 4,456).
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[C18CysDTPAGlu]2
Fmoc-Lys(Mtt)-OH (624.79 mg, 1.00 mmol), where Mtt is
(4-methylphenyl)diphenylmethyl, activated by 1 equiv of
PyBop and HOBt and 2 equiv of DIPEA in DMF was cou-
pled twice to Rink amide MBHA resin (0.78 mmol/g,
0.250 mmol scale, 0.320 g) by stirring the slurry suspension
for 1 h. The solution was filtered and the resin washed with
three portions of DMF and three portions of DCM. The Mtt
protecting group was removed by treatment with 2.0 mL of a
DCM/TIS/TFA (94:5:1) mixture. The treatment was repe-
ated several times until the solution became colorless. The
resin was washed with DMF and then the DTPAGlu pen-
taester chelating agent was linked, through its free carboxyl
function, to the a-NH2 of the lysine residue. This coupling
step was performed using 2.0 equiv of DTPAGlu pentaester
and O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluroni-
um, and 4 equiv of DIPEA in DMF as the solvent. The
coupling time, compared with that for the classic solid phase
peptide synthesis protocol, was increased up to 2 h and the
reaction was tested for completion by the Kaiser test. After
removal of the Fmoc protecting group by 30% piperidine in
DMF, and the coupling of the cysteine residue under stan-
dard conditions, the coupling of nonaoctanoic acid was
performed in a DCM/DMF (1:1) mixture according to the
previously described conditions. For deprotection and
cleavage, the fully protected fragment was treated with TFA
containing TIS (2.0%) and water (2.5%). The crude product
was precipitated at 0 C, washed several times with small
portions of water, and recrystallized from methanol and
water. The product was characterized by 1H NMR spec-
troscopy and electrospray spectrometry.
C18H37CONHCysLys(DTPAGlu)CONH2 (C18CysDT-
PAGlu): 1H MMR (chemical shifts d, tetramethylsilane as
the internal standard, DMSO-d6 as the solvent) 4.4 (m,
aCH Cys), 4.1 (m, 1H, aCH Lys), 3.5 (overlapped, 1H,
aCH Glu), 3.3 (s, 8H, NCH2COOH), 2.7–2.8 (m, 8H,
RNCH2CH2NR), 2.14 (m 2H, C(O)CH2CH2R), 1.87 (m,
cCH2 Lys), 1.76 (m, 2H, dCH2 Lys), 1.65 (m, 2H, bCH2
Lys), 1.5 (overlapped, 2H, RCH2CH3), 1.1–1.3 (m, 30 H,
15 CH2), 0.8 (t, 3H, 1 CH3). [M ? H]
? = 976 amu
(molecular weight 975).
The intramolecular disulfide bond reaction between the
cysteine residues was carried out under the same conditions
as described above in the case of C18CysL5CCK8, and the
identity of the product was confirmed by LC-MS analysis.
[C18H37COCysLys(DTPAGlu)CONH2]2: Rt = 27.15 min;
[M ? H]? = 1,950 amu (molecular weight 1,949).
Preparation of gadolinium complexes
The preparation of gadolinium complexes was carried out
by adding 2 equiv of GdCl3 to an aqueous solution of the
[C18CysDTPAGlu]2 ligand at neutral pH and room tem-
perature. The formation of the complexes was followed by
measuring the solvent proton relaxation rate (1/T1). The
excess of uncomplexed Gd(III) ions, which yields a vari-
ation of the observed relaxation rate, was removed by
filtering the complex solution left at pH 10 for 24 h with a
0.2-lm syringe filter, as already reported for other chelat-
ing amphiphilic monomers [11]. A xylenol orange
UV-spectrophotometric method was used to check for the
absence of free Gd(III) ions [31].
Solution preparation
Stock solutions of [C18CysDTPAGlu]2, [C18CysDTPA-
Glu(Gd)]2, and [C18CysL5CCK8]2 binary systems and
[C18CysDTPAGlu]2–[C18CysL5CCK8]2 and [C18Cys-
DTPAGlu(Gd)]2–[C18CysL5CCK8]2 ternary systems were
prepared in 0.1 M phosphate buffer at pH 7.4. Solutions
were stirred at room temperature until complete dissolution
of the monomers and were then filtered through a 0.45-lm
filter. All mixed solutions were prepared at 70:30 molar
ratio between [C18CysDTPAGlu]2 or [C18CysDTPA-
Glu(Gd)]2 and [C18CysL5CCK8]2.
UV spectroscopy
The concentrations of solutions containing peptide surfac-
tant were determined by absorbance measurement using a
JASCO V-5505 UV–vis spectrophotometer equipped with
a JASCO ETC.-505T Peltier temperature controller with a
1-cm quartz cuvette (Hellma). A molar absorptivity (e280)
of 6,845 M-1 cm-1 was used for CCK8; this value was
calculated according to the Edelhoch method [55], taking
into account contributions from tyrosine and tryptophan
present in the primary structure, which amount to 1,215
and 5,630 M-1 cm-1, respectively [56].
Fluorescence spectroscopy
Cmc values of aggregates were obtained by fluorescence
spectroscopy. Emission spectra were recorded at room
temperature using a JASCO model FP-750 spectrofluorim-
eter in 1.0 cm path length quartz cell. Equal excitation and
emission bandwidths were used throughout the experiments,
with a recording speed of 125 nm min-1 and automatic
selection of the time constant. The cmc values were mea-
sured by using ANS and pyrene as fluorescent probes. A
stock solution of pyrene (c = 1.0 9 10-3 M) was prepared
by adding a known weight of the compound to 20 wt%
ethanol in water. The small amount of ethanol in the pyrene
solution does not affect the spectral and self-aggregation
behavior of amphiphiles. Small aliquots of 1 9 10-4 M
aggregate solution, dissolved in 0.10 M phosphate buffer,
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pH 7.4, were added to a fixed volume (1.00 mL) of fluoro-
phore (1 9 10-5 M ANS or 2 9 10-6 M pyrene) directly in
the quartz cell. In the ANS method, the cmc values were
determined by linear least-squares fitting of the fluorescence
at 480 nm, upon excitation at 350 nm versus the amphiphile
concentration as previously reported [57, 58] In the pyrene
method, the cmc values were determined from the break
point of the fitting of I1/I3 upon excitation at 335 nm versus
the amphiphile concentration.
Circular dichroism experiments
Far-UV CD spectra were collected at room temperature
using a JASCO J-810 spectropolarimeter equipped with a
NesLab RTE111 thermal controller unit using a 1-mm
quartz cell. Other experimental settings were as follows:
scan speed 10 nm min-1; sensitivity 50 mdeg; time con-
stant 16 s; bandwidth 3 nm. CD measurements were
conducted on solutions containing peptide surfactant at
concentrations of 1 9 10-4 M in 2.5 mM phosphate buffer
at pH 7.4. The CD spectra were collected from 260 to
195 nm, corrected for the blank and adjusted for dilution.
Thermal profiles (CD vs. temperature, in the 10–80 and
80–10 C ranges) of the aggregates were recorded every
10 C, with an equilibration time of 20 min for each
measurement point. All samples were run in duplicate. The
Tt was determined from the maximum of the first derivative
of the heating and cooling curves.
Small angle neutron scattering measurements
SANS measurements were performed at various tempera-
tures (in the 10–80 and 80–10 C ranges) at the LOQ
instrument sited at the ISIS facility of the Rutherford
Appleton Laboratory (Chilton, UK). At the ISIS pulsed
neutron source, the LOQ instrument uses neutrons of
wavelengths ranging between 2.2 and 10 A˚ detected by a
time-of-flight analysis on a 64-cm2 two-dimensional detec-
tor placed 4.1 m from the sample [59], giving a q range of
0.006–0.24 A˚-1. Raw data were corrected for wavelength-
dependent sample transmissions, incident spectrum, and
detector efficiency and then put into absolute scattering
cross sections dR/dX by comparison with scattering from a
partially deuterated polystyrene standard. Samples were
heated up from 10 to 80 C at a rate of 1.0 C min-1, and
cross sections were measured at 10, 40, 50, 60, and 80 C.
After that, they were cooled down at a rate of 1.0 C min-1,
and cross sections were recorded at 50, 20, and 10 C.
Water proton relaxation measurements
The longitudinal water proton relaxation rates were mea-
sured with a Stelar Spinmaster (Mede, Pavia, Italy)
spectrometer operating at 20 MHz, by means of the stan-
dard inversion-recovery technique (16 experiments, two
scans). A typical 90 pulse width was 4 ls and the repro-
ducibility of the T1 data was ±0.5%. The temperature was
maintained at 25 C with a Stelar VTC-91 air-flow heater
equipped with a copper-constantan thermocouple (uncer-
tainty ±0.1 C). The proton 1/T1 NMRD profiles were
measured over a continuum of magnetic field strength from
0.00024 to 0.28 T (corresponding to 0.01–12 MHz proton
Larmor frequency) using a Stelar fast field-cycling relax-
ometer. This relaxometer works under complete computer
control with an absolute uncertainty in 1/T1 of ±1%. Data
points at 20 and 90 MHz were added to the experimental
NMRD profiles and were recorded with the Stelar Spin-
master (20 MHz) and with a JEOL (Tokyo, Japan) EX-90
(90 MHz) spectrometer, respectively.
17O measurements
Variable-temperature 17O NMR measurements were
recorded at 2.1 T using the JEOL EX-90 spectrometer,
equipped with a 5-mm probe, by using a D2O external lock.
The experimental settings were as follows: spectral width
10,000 Hz; 90 pulse (7 ls); acquisition time 10 ms; 1,000
scans; no sample spinning. Aqueous solutions containing
2.6% of the 17O isotope (Yeda, Israel) were used. The
observed transverse relaxation rates (R2obs
0 ) were calculated
from the signal width at half-height (Dvi2 = R2obspDvi2).
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